103 related articles for article (PubMed ID: 24086644)
1. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma.
Zhang L; Guo S; Schwab JH; Nielsen GP; Choy E; Ye S; Zhang Z; Mankin H; Hornicek FJ; Duan Z
PLoS One; 2013; 8(9):e75851. PubMed ID: 24086644
[TBL] [Abstract][Full Text] [Related]
2. Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers.
Barresi V; Ieni A; Branca G; Tuccari G
Dis Markers; 2014; 2014():514753. PubMed ID: 24591762
[TBL] [Abstract][Full Text] [Related]
3. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
[TBL] [Abstract][Full Text] [Related]
4. Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors.
Klubíčková N; Michal M; Kinkor Z; Soukup J; Ryška A; Brtková J; Lutonský M; Hájková V; Ptáková N; Michal M; Farkas M; Švajdler M
Virchows Arch; 2024 Apr; 484(4):621-627. PubMed ID: 37594643
[TBL] [Abstract][Full Text] [Related]
5. An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.
Nelson AC; Pillay N; Henderson S; Presneau N; Tirabosco R; Halai D; Berisha F; Flicek P; Stemple DL; Stern CD; Wardle FC; Flanagan AM
J Pathol; 2012 Nov; 228(3):274-85. PubMed ID: 22847733
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule targeting of brachyury transcription factor addiction in chordoma.
Sharifnia T; Wawer MJ; Chen T; Huang QY; Weir BA; Sizemore A; Lawlor MA; Goodale A; Cowley GS; Vazquez F; Ott CJ; Francis JM; Sassi S; Cogswell P; Sheppard HE; Zhang T; Gray NS; Clarke PA; Blagg J; Workman P; Sommer J; Hornicek F; Root DE; Hahn WC; Bradner JE; Wong KK; Clemons PA; Lin CY; Kotz JD; Schreiber SL
Nat Med; 2019 Feb; 25(2):292-300. PubMed ID: 30664779
[TBL] [Abstract][Full Text] [Related]
7. Development of a Small Molecule Downmodulator for the Transcription Factor Brachyury.
Chase DH; Bebenek AM; Nie P; Jaime-Figueroa S; Butrin A; Castro DA; Hines J; Linhares BM; Crews CM
Angew Chem Int Ed Engl; 2024 Apr; 63(14):e202316496. PubMed ID: 38348945
[TBL] [Abstract][Full Text] [Related]
8. Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma.
DeMaria PJ; Bilusic M; Park DM; Heery CR; Donahue RN; Madan RA; Bagheri MH; Strauss J; Shen V; Marté JL; Steinberg SM; Schlom J; Gilbert MR; Gulley JL
Oncologist; 2021 May; 26(5):e847-e858. PubMed ID: 33594772
[TBL] [Abstract][Full Text] [Related]
9. A rare case of chordoma cutis.
Jung D; Ko SM; Seo J; Park EJ; Kim KJ; Kim KH
J Cutan Pathol; 2023 Nov; 50(11):951-955. PubMed ID: 37654082
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study.
Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z
Front Oncol; 2020; 10():596330. PubMed ID: 33282745
[TBL] [Abstract][Full Text] [Related]
11. Germline findings in cancer predisposing genes from a small cohort of chordoma patients.
Raygada M; John L; Liu A; Schultz J; Thomas BJ; Bernstein D; Miettinen M; Raffeld M; Xi L; Tyagi M; Aldape K; Glod J; Reilly KM; Widemann BC; Wedekind MF
J Cancer Res Clin Oncol; 2024 May; 150(5):227. PubMed ID: 38700789
[TBL] [Abstract][Full Text] [Related]
12. The driver landscape of sporadic chordoma.
Tarpey PS; Behjati S; Young MD; Martincorena I; Alexandrov LB; Farndon SJ; Guzzo C; Hardy C; Latimer C; Butler AP; Teague JW; Shlien A; Futreal PA; Shah S; Bashashati A; Jamshidi F; Nielsen TO; Huntsman D; Baumhoer D; Brandner S; Wunder J; Dickson B; Cogswell P; Sommer J; Phillips JJ; Amary MF; Tirabosco R; Pillay N; Yip S; Stratton MR; Flanagan AM; Campbell PJ
Nat Commun; 2017 Oct; 8(1):890. PubMed ID: 29026114
[TBL] [Abstract][Full Text] [Related]
13. Impact of CDK Inhibitors on
Bette S; Haase L; Nell J; Grieser T; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TFE; Mellert K
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786326
[TBL] [Abstract][Full Text] [Related]
14. A Rare Chordoma-The Epiglottic chordoma.
Yu J; Wang L; Jiang N; Li C; Sun L
Ear Nose Throat J; 2022 Oct; ():1455613221132386. PubMed ID: 36219611
[TBL] [Abstract][Full Text] [Related]
15. Chordoma cells possess bone-dissolving activity at the bone invasion front.
Kawaai K; Oishi Y; Kuroda Y; Tamura R; Toda M; Matsuo K
Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38652222
[TBL] [Abstract][Full Text] [Related]
16. Advancement of PI3 Kinase Inhibitor Combination Therapies for PI3K-Aberrant Chordoma.
Heft Neal ME; Michmerhuizen NL; Kovatch KJ; Owen JHJ; Zhai J; Jiang H; McKean EL; Prince MEP; Brenner JC
J Neurol Surg B Skull Base; 2022 Feb; 83(1):87-98. PubMed ID: 35155075
[No Abstract] [Full Text] [Related]
17. Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury.
Williamson LM; Rive CM; Di Francesco D; Titmuss E; Chun HE; Brown SD; Milne K; Pleasance E; Lee AF; Yip S; Rosenbaum DG; Hasselblatt M; Johann PD; Kool M; Harvey M; Dix D; Renouf DJ; Holt RA; Nelson BH; Hirst M; Jones SJM; Laskin J; Rassekh SR; Deyell RJ; Marra MA
NPJ Precis Oncol; 2021 Dec; 5(1):103. PubMed ID: 34931022
[TBL] [Abstract][Full Text] [Related]
18. Low expression of miRNA-1290 associated with local invasion and recurrence in sacral chordoma.
Wang Y; Chen K; Chen H; Zhang K; Lu J; Mao H; Yang H
Int J Clin Exp Pathol; 2017; 10(11):10934-10940. PubMed ID: 31966437
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.
Miettinen M; Wang Z; Lasota J; Heery C; Schlom J; Palena C
Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.
Palena C; Roselli M; Litzinger MT; Ferroni P; Costarelli L; Spila A; Cavaliere F; Huang B; Fernando RI; Hamilton DH; Jochems C; Tsang KY; Cheng Q; Lyerly HK; Schlom J; Guadagni F
J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
